Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Effectiveness of radiotherapy for head and neck skin cancers: a single-institution study

  • Kim, Jae Wang (Department of Dermatology, Jeju National University School of Medicine, Jeju National University Hospital) ;
  • Yun, Byung Min (Department of Plastic and Reconstructive Surgery, Jeju National University School of Medicine, Jeju National University Hospital) ;
  • Shin, Myoung Soo (Department of Plastic and Reconstructive Surgery, Jeju National University School of Medicine, Jeju National University Hospital) ;
  • Kang, Jae Kyoung (Department of Plastic and Reconstructive Surgery, Jeju National University School of Medicine, Jeju National University Hospital) ;
  • Kim, JungJu (Medical Course, Jeju National University School of Medicine) ;
  • Kim, Young Suk (Department of Radiation Oncology, Jeju National University School of Medicine, Jeju National University Hospital)
  • Received : 2019.07.12
  • Accepted : 2019.09.30
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: External beam radiotherapy (EBRT) is a useful option to treat head and neck skin cancer patients who are not indicated for surgery. In this study, we evaluated the treatment outcomes of EBRT in an Asian population. Materials and Methods: The records from 19 head and neck skin cancer patients (10 with squamous cell carcinoma and 9 with basal cell carcinoma) who were treated with definitive or adjuvant EBRT from 2009 to 2017 were retrospectively reviewed. The radiotherapy doses administered ranged from 50 to 66 Gy (median, 55 Gy) with 2.0-2.75 Gy per daily fraction (median, 2.5 Gy). The T stage at presentation was as follows: Tis (1 patient), T1 (11 patients), T2 (6 patients), and T3 (1 patient). None had regional lymph node disease or distant metastasis at presentation. The local failure-free survival (LFFS) rates, toxicity, and cosmetic results were analyzed. Results: The median age was 75.5 years (range, 52.6 to 92.5 years). The median follow-up duration from the completion of radiotherapy was 44.9 months (range, 5.8 to 82.6 months). One local failure occurred in a patient with a 2.1-cm posterior neck squamous cell carcinoma at 32.5 months after radiotherapy (1/19, 5.3%). The 3-year LFFS rate was 91.7%. No patients died from skin cancer during follow-up, and no grade 3 complications occurred. The cosmetic outcomes were excellent for 16 (84.2%) and good for 3 (15.8%) of the 19 patients. Conclusion: EBRT offers good local control and cosmetic outcomes in patients with head and neck skin cancer, with no grade 3 complications.

Keywords

References

  1. Haseltine JM, Parker M, Wernicke AG, Nori D, Wu X, Parashar B. Clinical comparison of brachytherapy versus hypofractionated external beam radiation versus standard fractionation external beam radiation for non-melanomatous skin cancers. J Contemp Brachytherapy 2016;8:191-6. https://doi.org/10.5114/jcb.2016.60598
  2. van Hezewijk M, Creutzberg CL, Putter H, et al. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiother Oncol 2010;95:245-9. https://doi.org/10.1016/j.radonc.2010.02.024
  3. Kim HS, Cho EA, Bae JM, et al. Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006. J Korean Med Sci 2010;25:924-9. https://doi.org/10.3346/jkms.2010.25.6.924
  4. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia. I: Experience over 10 years. J Am Acad Dermatol 2005;53:253-60. https://doi.org/10.1016/j.jaad.2005.02.059
  5. Petit JY, Avril MF, Margulis A, et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000;105:2544-51. https://doi.org/10.1097/00006534-200006000-00039
  6. Veness MJ. The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. J Med Imaging Radiat Oncol 2008;52:278-86. https://doi.org/10.1111/j.1440-1673.2008.01956.x
  7. Veness M. Hypofractionated radiotherapy in older patients with non-melanoma skin cancer: less is better. Australas J Dermatol 2018;59:124-7. https://doi.org/10.1111/ajd.12609
  8. Kim JH. Radiation therapy in elderly skin cancer. J Korean Soc Ther Radiol Oncol 2008;26:113-7. https://doi.org/10.3857/JKSTRO.2008.26.2.113
  9. Thanh Pham T, Cross S, Gebski V, Veness MJ. Squamous cell carcinoma of the lip in Australian patients: definitive radiotherapy is an efficacious option to surgery in select patients. Dermatol Surg 2015;41:219-25. https://doi.org/10.1097/DSS.0000000000000240
  10. Ferro M, Deodato F, Macchia G, et al. Short-course radiotherapy in elderly patients with early stage nonmelanoma skin cancer: a phase II study. Cancer Invest 2015;33:34-8. https://doi.org/10.3109/07357907.2014.998835
  11. Bhatnagar A, Loper A. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer. Radiat Oncol 2010;5:87. https://doi.org/10.1186/1748-717X-5-87
  12. Nguyen NP, Ries T, Vock J, et al. Effectiveness of radiotherapy for elderly patients with non-melanoma skin cancer of the head. Geriatr Gerontol Int 2015;15:601-5. https://doi.org/10.1111/ggi.12319
  13. Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year. Brachytherapy 2013;12:134-40. https://doi.org/10.1016/j.brachy.2012.08.003
  14. Gauden R, Pracy M, Avery AM, Hodgetts I, Gauden S. HDR brachytherapy for superficial non-melanoma skin cancers. J Med Imaging Radiat Oncol 2013;57:212-7. https://doi.org/10.1111/j.1754-9485.2012.02466.x
  15. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-16. https://doi.org/10.1093/jnci/92.3.205
  16. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6. https://doi.org/10.1016/0360-3016(95)00060-C
  17. Pampena R, Palmieri T, Kyrgidis A, et al. Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): comparison between 2 different schedules. J Am Acad Dermatol 2016;74:341-7. https://doi.org/10.1016/j.jaad.2015.09.031
  18. Kang JK, Yun BM, Song JK, Shin MS. Non-melanocytic skin cancers of the head and neck: a clinical study in Jeju Province. Arch Plast Surg 2017;44:313-8. https://doi.org/10.5999/aps.2017.44.4.313
  19. Tsao MN, Tsang RW, Liu FF, Panzarella T, Rotstein L. Radiotherapy management for squamous cell carcinoma of the nasal skin: the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 2002;52:973-9. https://doi.org/10.1016/S0360-3016(01)02752-3
  20. Veness M, Richards S. Role of modern radiotherapy in treating skin cancer. Australas J Dermatol 2003;44:159-66. https://doi.org/10.1046/j.1440-0960.2003.06711.x
  21. Jin HR, Lee JY, Lee DW, et al. Primary facial skin cancer: clinical characteristics and surgical outcome in Chungbuk Province, Korea. J Korean Med Sci 2005;20:279-82. https://doi.org/10.3346/jkms.2005.20.2.279
  22. Silva JJ, Tsang RW, Panzarella T, Levin W, Wells W. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 2000;47:451-9. https://doi.org/10.1016/S0360-3016(00)00410-7
  23. Momm F, Becker G, Bartelt S, Guttenberger R. The elderly, fragile tumor patient: radiotherapy as an effective and most feasible treatment modality. J Pain Symptom Manag 2004;27:3-4. https://doi.org/10.1016/j.jpainsymman.2003.10.004
  24. Valeriani M, Nicosia L, Agolli L, et al. Mono- and bi-weekly hypofractionated radiation therapy for the treatment of epithelial skin cancer in very elderly patients. Anticancer Res 2017;37:825-30. https://doi.org/10.21873/anticanres.11384
  25. Newlands C, Currie R, Memon A, Whitaker S, Woolford T. Non-melanoma skin cancer : Uni ted Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016;130(S2):S125-S132.
  26. Lovett RD, Perez CA, Shapiro SJ, Garcia DM. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 1990;19:235-42.
  27. Olschewski T, Bajor K, Lang B, Lang E, Seegenschmiedt MH. Radiotherapy of basal cell carcinoma of the face and head: Importance of low dose per fraction on long-term outcome. J Dtsch Dermatol Ges 2006;4:124-30. https://doi.org/10.1111/j.1610-0387.2006.05880.x
  28. Rong Y, Zuo L, Shang L, Bazan JG. Radiotherapy treatment for nonmelanoma skin cancer. Expert Rev Anticancer Ther 2015;15:765-76. https://doi.org/10.1586/14737140.2015.1042865
  29. Guix B, Finestres F, Tello J, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custommade surface molds. Int J Radiat Oncol Biol Phys 2000;47:95-102. https://doi.org/10.1016/S0360-3016(99)00547-7
  30. Maronas M, Guinot JL, Arribas L, et al. Treatment of facial cutaneous carcinoma with high-dose rate contact brachytherapy with customized molds. Brachytherapy 2011;10:221-7. https://doi.org/10.1016/j.brachy.2010.08.005

Cited by

  1. New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era vol.10, pp.4, 2019, https://doi.org/10.3390/jcm10040587